Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study

Archives of Internal Medicine

Volumn 159, Issue 18, 1999, Pages 2206-2212

  Lloyd Jones, Donald M ^a,b   Evans, Jane C ^a,c   Larson, Martin G ^a,c   O'Donnell, Christopher J ^a,b   Wilson, Peter W F ^a,c   Levy, Daniel ^a,c,d,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL PRACTICE; DIABETES MELLITUS; DISEASE CLASSIFICATION; HEALTH CARE POLICY; HEART DISEASE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; HYPERTENSION; MALE; MASSACHUSETTS; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0033547206     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.18.2206     Document Type: Article

References (27)

1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
2. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
3. Fuster V, Pearson TA. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol. 1996;27:957-1047.
4. Kaplan NM. Systemic hypertension: mechanisms and diagnosis. In: Braunwald E, ed. Heart Disease. 5th ed. Philadelphia, Pa: WB Saunders Co; 1997;807-839.
5. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation. 1991;83:356-362.
6. Cupples LA, D'Agostino RB, Kiely D. The Framingham Heart Study, Section 35: An Epidemiological Investigation of Cardiovascular Disease: Survival Following Cardiovascular Events: 30 Year Follow-up. Bethesda, Md: National Heart, Lung and Blood Institute; 1988.
7. Cupples LA, Ramaswamy R, Christiansen JC, Belanger AJ, D'Agostino RB. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 38: The Relationship Between Sporadically Measured Variables and the Risk of Cardiovascular Disease and Death: The Framingham Heart Study, 30-34 Year Follow-up. Bethesda, Md: National Heart, Lung, and Blood Institute; 1988.
8. Jousilahti P, Toumilehto J, Vartiainen E, et al. Importance of risk factor clustering in coronary heart disease mortality and incidence in eastern Finland. J Cardiovasc Risk. 1995;2:63-70.
9. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-183.
10. Dawber TR, Meadors GF, Moore FE. Epidemiologic approaches to heart disease: the Framingham study. Am J Public Health. 1951;41:279-286.
11. Gordon T, Moore FE, Shurtleff D, Dawber TR. Some methodologic problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J Chronic Dis. 1959;10:186-206.
12. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham study. Ann N Y Acad Sci. 1963;107:539-556.
13. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham offspring study. Am J Epidemiol. 1979;110:281-290.
14. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study: design and preliminary data. Prev Med. 1975;4:518-525.
15. SAS Institute. SAS/STATSoftware: Changes and Enhancements Through Release 6.11. Cary, NC: SAS Institute Inc; 1996.
16. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-1847.
17. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
18. Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
19. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials: The INDANA Investigators. Ann Intern Med. 1997;126:761-767.
20. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA. 1997;277:739-745.
21. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J. Cost-effectiveness analysis in heart disease, part II: preventive therapies. Prog Cardiovasc Dis. 1995;37:243-271.
22. Littenberg B, Garber AM, Sox HC. Screening for hypertension. Ann Intern Med. 1990;112:192-202.
23. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:408-413.
24. Stason WB, Weinstein MC. Allocation of resources to manage hypertension. N Engl J Med. 1977;296:732-739.
25. Pogue VA, Ellis C, Michel J, Francis CK. New staging system of the fifth Joint National Committee report on the detection, evaluation, and treatment of high blood pressure (JNC-V) alters assessment of the severity and treatment of hypertension. Hypertension. 1996;28:713-718.
26. Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care. 1994; 17:1247-1251.
27. Gupta R, Guptha S, Gupta VP, Prakash H. Prevalence and determinants of hypertension in the urban population of Jaipur in western India. J Hypertens. 1995; 13:1193-1200.